Cardinal Health, Prime Therapeutics renew distribution deal
DUBLIN, Ohio and ST. PAUL, Minn. — A healthcare services company will continue to serve as the primary pharmaceutical supply chain partner for a pharmacy benefit manager’s mail-order business.
Cardinal Health said it has renewed a three-year agreement with Prime Therapeutics and will continue to deliver pharmaceutical distribution services for PrimeMail, the Prime Therapeutics’ mail-order pharmacy. Prime Therapeutics currently serves nearly 17 million members through Blue Cross and Blue Shield plans, employer and union groups, and third-party administrators, according to the company.
Cardinal Health also said it will continue to offer Prime Therapeutics additional supply chain optimization services to help improve the latter’s operational efficiency.
"We look forward to continuing to deliver the kind of flexible and innovative pharmaceutical distribution services that help Prime Therapeutics to efficiently and effectively serve its patients’ medication needs," said Jon Giacomin, president of Cardinal Health’s U.S. pharmaceutical distribution business. "This renewed agreement is an excellent example of our commitment to building mutually beneficial customer relationships that enable us to grow our pharmaceutical distribution business while also improving the overall costs of health care."
Compliant Pharmacy Alliance appoints VP marketing
STOUGHTON, Wis. — A pharmacy purchasing cooperative announced that Mark LaPorte has joined its team as VP marketing.
In his new role at Compliant Pharmacy Alliance, LaPorte will focus on coordinating and facilitating CPA membership growth and retention, recruiting, communications and marketing. An industry veteran, LaPorte has more than 25 years of experience in sales, sales management, sales training and marketing in the healthcare industry.
“The addition of Mark to our marketing team further strengthens our ability to continue the rapid growth CPA has enjoyed over the years," CPA CEO Ed Heckman said. "Mark’s comprehensive marketing and sales management experience will greatly benefit CPA and our co-op membership.”
FTC issues ‘second request’ to Teva, Cephalon over deal
JERUSALEM and FRAZER, Pa. — Before they can move ahead with their deal, drug makers Teva and Cephalon must provide the Federal Trade Commission with additional information related to Teva’s pending acquisition of Cephalon.
The "second request," as it often is called, is to extend the Hart-Scott-Rodino Antitrust Improvements Act of 1976 waiting period until thirty days after the parties substantially have complied with the request, the FTC said. Teva and Cephalon said they are in full cooperation with the FTC and continue to expect the acquisition will be completed in third quarter 2011.
As previously reported by Drug Store News, generic drug maker Teva said that it would buy Frazer, Pa.-based Cephalon for $6.8 billion in May.